Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2020.7551DOI Listing

Publication Analysis

Top Keywords

intravascular microaxial
4
microaxial left
4
left ventricular
4
ventricular assist
4
assist device
4
device intra-aortic
4
intra-aortic balloon
4
balloon pump
4
pump cardiogenic
4
cardiogenic shock
4

Similar Publications

Background: The use of mechanical circulatory support devices for high-risk percutaneous coronary intervention (PCI) has increased over the past decade despite limited data of benefit. We sought to examine the association between intravascular microaxial left ventricular assist device (LVAD) versus intra-aortic balloon pump use in patients without cardiogenic shock (CS) undergoing PCI.

Methods And Results: This retrospective study analyzed claims data from a large, insured population who underwent PCI without CS from April 1, 2016 to July 31, 2022.

View Article and Find Full Text PDF

: Patients in cardiogenic shock (CS) may be successfully bridged using intravascular micro-axial left ventricular assist devices (M-LVADs) for recovery or determination of definitive therapy. : One hundred and seven CS patients implanted with M-LVADs from January 2020 to May 2024 were divided into four groups; group-1: 34 patients (transplant); group-2: 25 patients (LVAD); group-3: 42 patients (postcardiotomy CS (PCCS)); group-4: 6 patients (decision/recovery but excluded from analysis). Multivariable logistic regression and Multivariable Coxregression models identified predictors of early -hospital and late mortality, and Odds ratios (ORs) and hazard ratios (HRs) with < 0.

View Article and Find Full Text PDF

Background: In recent years, intravascular micro-axial blood pumps have been increasingly used in the treatment of patients with cardiogenic shock. The flow rate of such blood pumps requires adjustment based on the patient's physiological condition. Compared to a stable flow state with fixed rotation speed, adjusting the speed of blood pump impeller to alter flow rate may lead to additional hemolysis.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on an Automatic IMpella Optimal Unloading System (AIMOUS) designed to control the speed of the Impella pump, improving heart protection during cardiovascular diseases by maintaining left ventricular (LV) unloading effectively.
  • Using an animal model, AIMOUS was validated to keep LV systolic pressure stable, showing success in managing fluctuations in blood volume without losing efficiency.
  • Results indicated that AIMOUS significantly enhanced LV function and minimized heart tissue damage in acute ischemia-reperfusion situations compared to standard Impella support, suggesting its potential for better clinical outcomes.
View Article and Find Full Text PDF

The utilization of a minimally invasively placed catheter-mounted intravascular micro-axial flow blood pump (IMFBP) is increasing in the population with advanced heart failure. The current development of IMFBPs dates back around the 1990s, namely the Hemopump with a wire-drive system and the Valvopump with a direct-drive system. The wire-drive IMFBPs can use a brushless motor in an external console unit to transmit rotational force through the drive wire rotating the impeller inside the body.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!